News & Updates

In the phase III LMS04 trial, induction therapy with doxorubicin and trabectedin, followed by trabectedin maintenance, improved survival in patients with metastatic or surgically unresectable soft-tissue or uterine leiomyosarcoma (LMS).

For both women and men, BMI that is outside of the normal category during the preconception or early-pregnancy periods is a risk factor for lower fecundability, subfertility, and miscarriage, as reported in a cohort study.

In women with systemic lupus erythematosus (SLE), factors such as disease activity prior to and during conception as well as the presence of secondary antiphospholipid syndrome convey heightened risk of adverse pregnancy outcomes, according to the results of a systematic review and meta-analysis.

Sacubitril/valsartan appears to be safe and beneficial in the treatment of children with heart failure (HF) attributable to systemic left ventricular systolic dysfunction (LVSD), with the drug having comparable efficacy as enalapril, according to the 52-week data from the phase 2/3 PANORAMA-HF* trial.

A pharmacist-managed telemedicine during the COVID-19 pandemic has resulted in improvements in appointment adherence in the hospital-based (HB) clinic and increased reimbursement in the physician-based (PB) clinic, reports a study. Healthcare outcomes, however, show no significant change.

A study has shown that carbon dioxide (CO₂) laser excision may be an innovative approach for treating xanthelasma palpebrarum (XP), particularly for large lesions.